دورية أكاديمية

O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)

التفاصيل البيبلوغرافية
العنوان: O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)
المؤلفون: Patel, M., Siena, S., Demetri, G., Doebele, R., Chae, Y., Conkling, P., Garrido-Laguna, I., Longo, F., Rolfo, C., Sigal, D., Drilon, A., Liu, S., Goto, K., Bazhenova, L., Lonardi, S., Ciardiello, F., Huang, X., Osborne, S., Aziez, A., de Braud, F.
المصدر: In Annals of Oncology July 2020 31 Supplement 3:232-233
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2020.04.056